Physician profile
Usman Sultan
NPI 1851826622
$8,787.08
in general payments reported to CMS, 2019-2025
28 companies · $1,792 in 2025
The $1,792 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.56 · 2020: $425 · 2021: $3,264 · 2022: $1,440 · 2023: $903 · 2024: $941 · 2025: $1,792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,601 · Travel and Lodging: $34.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,601.37 |
| Travel and Lodging | $34.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,325.25 | 2020-2025 | Augment Injectable, Hoffmann, Ortholoc 2 Lapifuse |
| Arthrex, INC. | $1,618.00 | 2021 | |
| Medinc of Texas | $820.59 | 2021-2022 | |
| Medtronic USA, INC. | $358.50 | 2020 | |
| Smith+Nephew, INC. | $258.78 | 2021-2025 | Renasys Touch, Renasys Go V2 Home |
| Mimedx Group, INC. | $218.43 | 2024-2025 | |
| Cvrx, INC. | $197.62 | 2024 | Barostim Neo System |
| Angiodynamics, INC. | $151.74 | 2024-2025 | Alphavac |
| Heartflow, INC. | $147.04 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $90.98 | 2023 | Lifevest |
| Paragon 28, INC. | $66.29 | 2023-2025 | Precision Mis Bunion, Activcore Nail |
| Amgen INC. | $56.02 | 2023-2025 | Repatha, Krystexxa |
| Tactile Systems Technology INC | $53.41 | 2025 | Flexitouch Plus, Nimbl |
| Paratek Pharmaceuticals, INC. | $51.63 | 2025 | Nuzyra |
| Anika Therapeutics, INC. | $48.29 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $46.99 | 2023-2024 | Diamondback Peripheral, Cardiomems |
| Grt US Holding, INC. | $46.71 | 2021 | |
| Kerecis Limited | $40.09 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Horizon Therapeutics Plc | $28.26 | 2021 | |
| Regeneron Pharmaceuticals, INC. | $27.06 | 2025 | Evkeeza |
| Ani Pharmaceuticals, INC. | $24.54 | 2025 | Purified Cortrophin Gel |
| Janssen Pharmaceuticals, INC | $22.56 | 2019 | |
| Bolton Medical INC | $17.96 | 2024 | Treo Abdominal Stent-Graft System |
| Innovation Technologies INC | $16.79 | 2025 | Irrisept |
| Bioventus LLC | $15.67 | 2023 | Exogen Ultrasound Bone Healing System |
| Curonix LLC | $14.47 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Treace Medical Concepts, INC. | $14.43 | 2022 | |
| Arthrosurface Incorporated | $8.98 | 2025 | Toe Motiontm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usman Sultan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.